NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07/30/2026
Back to search
Official data from USPTO
GLOBAL AUTOIMMUNE INSTITUTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GLOBAL AUTOIMMUNE INSTITUTE
ST13
US500000088703664Class
35, 36, 41
Filing
88703664
Registration
6071504
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
07/30/2026
Trademark type
Word
Nice classes
35, 36, 41
Filing date
11/22/2019
Registration date
06/02/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/30/2026
Last transaction
07/30/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
First use anywhere
2019-05-00
First use in commerce
2019-05-00
Drawing code
4
Owner type
99
Owner location
McLean, VA, US
Examiner
KETCHUM, BRENDAN J
Current location
Historical data usage
Holders and representatives
Holders
Walter and Jean Boek Global Autoimmune Institute
Representatives
David M. Abrahams WEBSTER, CHAMBERLAIN & BEAN, LLP
Technical classification
Nice Classes
Class 35Class 36Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting public awareness of autoimmune diseasesneurological disorderscancer and diagnosis and treatment of autoimmune diseasesneurological disorderscancer; promoting awareness of the interdisciplinary practice of medicine in the fields of autoimmune diseasesneurological disorders and cancer
Class 36
Providing grants to fund research in the fields of autoimmune diseasesneurological disorders and cancer; providing grants to support the interdisciplinary practice of medicine in the fields of autoimmune diseasesneurological disorders and cancer; providing grants to fund education in the fields of autoimmune diseasesneurological disorders and cancer; charitable fundraising services for promoting researcheducation and other activities relating to the fields of autoimmune diseasesneurological disorders and cancer
Class 41
Educational servicesarranging and conducting seminarsnon-downloadable webinarssymposiapanel discussionslectures and educational conferences in the fields of autoimmune diseasesneurological disorders and cancer; producing and providing podcasts in the fields of autoimmune diseasesneurological disorders and cancer
Publications
History of USPTO decisions and trademark events.
18 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
07/30/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/30/2026
ES8R
TEAS SECTION 8 RECEIVED
05/29/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/02/2025
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
06/02/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/29/2020
ALIE
ASSIGNED TO LIE
04/28/2020
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
04/22/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/31/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/31/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/31/2020
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
03/03/2020
GPRA
PRIORITY ACTION E-MAILED
03/03/2020
CPRA
PRIORITY ACTION WRITTEN
03/03/2020
DOCK
ASSIGNED TO EXAMINER
02/26/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/02/2019
NWAP
NEW APPLICATION ENTERED
11/26/2019
Continuous trademark protection
Get notified about every new filing that threatens GLOBAL AUTOIMMUNE INSTITUTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.